SCHEMBL16319507

SCHEMBL16319507

Cc1cc(Nc2cc(-c3ccco3)n[nH]2)nc(Nc2ccc(NC(=O)N(S)c3ccc(Cl)c(C(F)(F)F)c3)nc2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 5/20 0.35
MAPK14 Q16539 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
BTK Q06187 1/20 0.33
MAPT P10636 4/20 0.33
RAF1 P04049 2/20 0.33
IGF1R P08069 1/20 0.32
RAPGEF3 O95398 2/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
TEK Q02763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16319831 0.89 BRAF (0.39) BRAFMAPK14BTKMAPTRAF1
SCHEMBL16320149 0.88 BTK (0.36) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320206 0.88 BRAF (0.44) BRAFMAPK14NPSR1HTTMEN1
SCHEMBL16323158 0.88 BRAF (0.36) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320252 0.87 IGF1R (0.35) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320371 0.87 BRAF (0.33) BRAFMAPK14HTTMEN1KMT2A
SCHEMBL16319467 0.86 IGF1R (0.35) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16320222 0.85 IGF1R (0.41) BRAFMAPK14BTKRAF1IGF1R
SCHEMBL16319505 0.85 BRAF (0.39) BRAFMAPK14NPSR1HTTMEN1
SCHEMBL16319707 0.85 IGF1R (0.34) BRAFMAPK14MEN1KMT2ABTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221798-B2 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof Zhejian Hisun Pharmaceutical Co., Ltd. (CN) 2015-12-29 US disclosed
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF MAP4K2, MAP4K1, MAP4K3 BRAF 84/4885MAPK14 114/4885NPSR1 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.